What Are Alpha-Glucosidase Inhibitors for Diabetes? - WebMD
2023年5月21日 · Alpha-glucosidase inhibitors are pills that treat type 2 diabetes. There are two medications in this group, or class, of drugs: acarbose (Precose) and miglitol (Glyset). They help keep the...
Alpha-glucosidase inhibitors for treatment of diabetes mellitus
2024年1月4日 · Alpha-glucosidase inhibitors lower blood glucose by modifying the intestinal absorption of carbohydrates. The glycemic efficacy, adverse effects, and dosing of alpha-glucosidase inhibitors will be discussed here. Other oral hypoglycemic drugs are …
Alpha Glucosidase Inhibitors - StatPearls - NCBI Bookshelf
2024年2月28日 · Alpha-glucosidase inhibitors are effective in patients with type 2 diabetes in improving the metabolic profile and potentially reducing the risk of long-term complications of hyperglycemia. They may be used as monotherapy or in combination with other antihyperglycemic drugs and insulin.
Alpha Glucosidase Inhibitors - The Johns Hopkins Patient Guide to Diabetes
Alpha glucosidase inhibitors are recommended for persons with type 2 diabetes who have poorly controlled blood glucose despite using other diabetic medications. These are typically not first-line, but can be used in special situations.
α-Glucosidase Inhibitors for Patients With Type 2 Diabetes
2005年1月1日 · Alpha-glucosidase inhibitors (AGIs; acarbose, miglitol, voglibose) are widely used in the treatment of patients with type 2 diabetes. AGIs delay the absorption of carbohydrates from the small intestine and thus have a lowering effect on …
Alpha-glucosidase inhibitor - Wikipedia
Alpha-glucosidase inhibitors (AGIs) are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar). They are found in raw plants/herbs such as cinnamon and bacteria (containing the inhibitor acarbose ).
α-Glucosidase inhibitors and their use in clinical practice
α-Glucosidase inhibitors can be used as a first-line drug in newly diagnosed type 2 diabetes insufficiently treated with diet and exercise alone, as well as in combination with all oral anti-diabetics and insulin if monotherapy with these drugs fails to achieve the targets for HbA 1c and post-prandial blood glucose.
Alpha‐glucosidase inhibitors for type 2 diabetes mellitus
Alpha‐glucosidase inhibitors such as acarbose or miglitol, have the potential to improve glycemic control in type 2 diabetes mellitus. The true value of these agents, especially in relation to diabetes related mortality and morbidity, has never been ...
Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes …
Alpha-glucosidase inhibitors (AGIs) are drugs that inhibit the absorption of carbohydrates from the gut and may be used in the treatment of patients with type 2 diabetes or impaired glucose tolerance. There is currently no evidence that AGIs are beneficial to prevent or delay mortality or micro- or macrovascular complications in type 2 diabetes.
Alpha Glucosidase Inhibitors - PubMed
Alpha-glucosidase inhibitors (AGIs) are therapeutic agents in managing type 2 diabetes. Acarbose and miglitol are FDA-approved and are prominent members of this drug class. AGIs are also prescribed for patients with impaired glucose tolerance, demonstrating their utility in …